Companies: 10,795·Total market cap: $144.5T
Response Oncology, Inc.

Response Oncology, Inc.

ROIXOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$12
P/E Ratio
52W High
52W Low

Response Oncology, Inc. (ROIX) Market Cap & Net Worth

Live market cap, enterprise value, and global rank — multi-year chart and annual table below.

roix · market cap & enterprise value · FMP · as of May 15, 2023

Core market cap & key metrics

As of May 15, 2023, Response Oncology, Inc. (ROIX) has a market cap — also referred to as its net worth or valuation — of $12, making it one of the top most valuable companies globally. Market Cap = $0.00 × shares outstanding.

Market Cap (Net Worth)$12roix market cap 2026
Enterprise ValuemktCap + debt − cash
1-Year Changevs one year ago
Global Rankinglargest company by mkt cap
All-Time High$0roix highest market cap ever
Stock Price$0.00OTC · May 15, 2023
How is Market Cap calculated?Market Cap = Stock Price × Shares Outstanding

About Market Cap, Net Worth & Valuation

Response Oncology, Inc. (ROIX) has a market cap — also referred to as its net worth or valuation — of $12 as of May 15, 2023, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.

Response Oncology, Inc. reached its all-time high market cap of $0 on —. Comparing the Response Oncology, Inc. market cap history illustrates one of the most extraordinary corporate growth stories.

Investors frequently compare Response Oncology, Inc. net worth vs peers and ask how Response Oncology, Inc. valuation compares to other countries. Its market cap reflects continued investor confidence.

Data: FMP · year-end market cap · not investment advice

Frequently Asked Questions

ROIX market cap · 6 questions

Response Oncology, Inc.'s net worth — measured as market capitalization — is $12 as of May 15, 2023. It ranks #0 globally. Market Cap = $$0.00 (price) × shares outstanding.

ROIX net worth 2026market cap vs book valuelargest companies by market cap
Data: Financial Modeling Prep · Market cap updates daily · For informational purposes only, not investment advice.